In situ AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteins.

[1]  A. Tall,et al.  Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[2]  L. Mucke,et al.  Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid β Peptides But Not on Plaque Formation , 2002, The Journal of Neuroscience.

[3]  Bruce J Aronow,et al.  Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Yip,et al.  Aβ42-Peptide Assembly on Lipid Bilayers , 2002 .

[5]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[6]  Xianlin Han,et al.  Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice , 2001, Neurochemistry International.

[7]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Mervyn J Miles,et al.  Enhanced imaging of DNA via active quality factor control , 2001 .

[9]  J McLaurin,et al.  Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. , 2001, Journal of molecular biology.

[10]  M. Miles,et al.  High-Q dynamic force microscopy in liquid and its application to living cells. , 2001, Biophysical journal.

[11]  C. Yip,et al.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. , 2001, Biophysical journal.

[12]  Javier Tamayo,et al.  Active quality factor control in liquids for force spectroscopy , 2000 .

[13]  Javier Tamayo,et al.  Piconewton regime dynamic force microscopy in liquid , 2000 .

[14]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Wilson,et al.  Clusterin is a secreted mammalian chaperone. , 2000, Trends in biochemical sciences.

[16]  K. V. van Dijk,et al.  Apolipoprotein E Participates in the Regulation of Very Low Density Lipoprotein-Triglyceride Secretion by the Liver* , 1999, The Journal of Biological Chemistry.

[17]  P. Fraser,et al.  Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones* , 1999, The Journal of Biological Chemistry.

[18]  A. Fagan,et al.  Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (−/−), and Human apoE Transgenic Mice* , 1999, The Journal of Biological Chemistry.

[19]  H. Lin,et al.  Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. , 1999, Biochemistry.

[20]  M. Davies,et al.  Morphological Development of β(1-40) Amyloid Fibrils , 1999, Experimental Neurology.

[21]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[22]  D. Holtzman,et al.  In situ atomic force microscopy study of Alzheimer’s β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation , 1999 .

[23]  T. S. Spisz,et al.  Automated sizing of DNA fragments in atomic force microscope images , 1998, Medical and Biological Engineering and Computing.

[24]  R. Lal,et al.  Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel* , 1998, The Journal of Biological Chemistry.

[25]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Linton,et al.  Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. , 1998, The Journal of clinical investigation.

[27]  S. Sligar,et al.  Imaging and manipulation of high-density lipoproteins. , 1997, Biophysical journal.

[28]  J. Villarrubia.  Algorithms for Scanned Probe Microscope Image Simulation, Surface Reconstruction, and Tip Estimation , 1997, Journal of research of the National Institute of Standards and Technology.

[29]  T. Morgan,et al.  Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNAin Vivoandin Vitro , 1997, Experimental Neurology.

[30]  A. Fagan,et al.  Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[31]  P. May,et al.  Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity , 1996 .

[32]  Guido Gosselink,et al.  Adsorption of high density lipoproteins (HDL) on solid surfaces , 1996 .

[33]  T. Willnow,et al.  Lipoprotein and receptor interactions in vivo , 1995, Current opinion in lipidology.

[34]  E. Matsubara,et al.  Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction (*) , 1995, The Journal of Biological Chemistry.

[35]  B. Tycko,et al.  The apolipoprotein ε4 allele in patients with Alzheimer's disease , 1993, Annals of neurology.

[36]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[37]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[38]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[39]  T. Wisniewski,et al.  The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. , 1993, The Biochemical journal.

[40]  C. Finch,et al.  Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration , 1992, Trends in Neurosciences.

[41]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[42]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[43]  R. Mahley,et al.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.

[44]  J. Taylor,et al.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.

[45]  G. Bruns,et al.  Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. , 1985, The Journal of biological chemistry.

[46]  M. Brown,et al.  Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. , 1982, The Journal of biological chemistry.

[47]  G. Vega,et al.  Apolipoproteins in human cerebrospinal fluid. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[49]  T. Forte,et al.  [26] Electron microscopy of negatively stained lipoproteins , 1986 .